HKHwa Young Kim

Hwa Young Kim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hwa Young Kim has a total of 101 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Diabetes-related distress and perspectives on disability registration in pancreatic endocrine dysfunction: a multicenter web-based survey in Korea

    by Hwa Young Kim, Hye-Ryeon Park, Mi Yang, Kwang Hoon Kim, Sunyoung Lee, Hakyung Lee, Dae Jung Kim, Seok O Park, Han Jin Oh, Minjeong Gu, et al.

    Purpose: This study aimed to assess diabetes-related distress and perspectives on disability registration among people with type 1 diabetes and other forms of pancreatic endocrine dysfunction (PED) and caregivers of pediatric patients in Korea.Methods: A multicenter web-based survey included individuals with type 1 diabetes or those who had undergone pancreatectomy or pancreas transplantation; caregivers responded on behalf of pediatric participants when applicable. Diabetes-related distress was assessed using the Diabetes Distress Scale (DDS), with a score ≥3 indicating elevated diabetes-related distress. Multivariable regression analyses were performed to identify factors associated with distress and perspectives on disability registration.Results: A total of 852 respondents (median patient age, 19.0 years; 49.2% aged ≤18 years; 98.5% with type 1 diabetes) were included. The median DDS score was 3.2 (interquartile range, 2.7–3.7), and 64.8% had a DDS score ≥3. Questionnaires concerning adult participants more frequently had DDS scores ≥3 than those concerning pediatric participants (69.8% vs. 59.6%, P=0.002). Emotional burden was the predominant domain (88.5% scoring ≥3). Overall, 97.1% of participants supported disability registration. Older age (B=–0.013), shorter duration of diabetes (B=–0.012), and diabetes-related complications (B=0.395) were associated with higher distress. Higher DDS scores were associated with support for disability registration (odds ratio, 2.89; 95% confidence interval, 1.64–5.11).Conclusion: Diabetes-related distress is common in people with type 1 diabetes and other forms of PED, with emotional burden being particularly prominent. Higher DDS scores were associated with more favorable views of disability registration, suggesting that perceived psychosocial burden may influence perspectives on formal recognition and support.

  • Open Access

    Development of a glycated hemoglobin prediction model using continuous glucose monitoring metrics in pediatric type 1 diabetes mellitus: insights into average glucose and recent glycemic trends

    by Hakyung Lee, Mi Yang, Hwa Young Kim, Jaehyun Kim

    Purpose: Given the limitations of glycated hemoglobin (HbA1c), continuous glucose monitoring (CGM) metrics have been proposed as complementary indicators of glycemic control. This study evaluated the association between CGM metrics and HbA1c and developed HbA1c prediction models in Korean pediatric patients with type 1 diabetes mellitus (T1DM).Methods: We retrospectively analyzed CGM data from 85 patients aged 2–18 years using real-time CGM systems (G6 or G7). CGM records over 12 weeks were segmented into 5 intervals (0–2, 0–4, 4–8, 8–12, and 0–12 weeks) prior to HbA1c measurement. Metrics included time-in-range (TIR), time-above-range (TAR), time-below-range, time-in-tight-range, coefficient of variation, and average glucose. HbA1c prediction models were constructed using ridge regression and validated in a separate test dataset.Results: TIR consistently showed the strongest negative association with HbA1c, while TAR and average glucose showed the strongest positive associations. Among all intervals, 0- to 4-week CGM data demonstrated the strongest relationship with HbA1c (all P<0.05). Average glucose achieved the best explanatory power among all metrics (R²=0.83, Akaike Information Criterion=84.34), and prediction models incorporating average glucose and TAR yielded the lowest mean squared error (0.15) and highest R² (0.83), with robust results in the test dataset.Conclusion: Short-term CGM metrics, particularly average glucose during the 0–4 weeks preceding HbA1c testing, are strong predictors of HbA1c. These findings support the clinical utility of recent CGM data in optimizing individualized glycemic management in pediatric patients with T1DM.


  • Very-early-onset autosomal dominant polycystic kidney disease coexisting with congenital adrenal hyperplasia in a newborn: a case report

    by Chang Kim, Hwa Young Kim, Young Hwa Jung, Chang Won Choi, Jaehyun Kim, Ji Hyun Kim

    This case report describes a newborn diagnosed with very-early-onset autosomal dominant polycystic kidney disease (VEO-ADPKD) and congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. The patient presented with prenatally detected kidney cysts and exhibited clinical and laboratory features consistent with salt-wasting, including markedly elevated 17-hydroxyprogesterone levels, requiring treatment with hydrocortisone, fludrocortisone, and sodium chloride. Genetic analysis revealed a de novo truncating variant in PKD1 and two variants in CYP21A2. Hypertension developed at 3 years and 7 months despite unchanged steroid replacement doses, requiring antihypertensive treatment, and resolved after mineralocorticoid dose reduction. This case highlights the competing therapeutic demands of concurrent salt-wasting CAH and VEO-ADPKD, underscoring the importance of early genetic evaluation and integrated multidisciplinary surveillance.

  • Open Access

    Anthropometric trajectories of Korean children and adolescents with severe obesity

    by Jeongho Han, Hakyung Lee, Dong Jun Ha, Jieun Lee, Yong Hee Hong, Hwa Young Kim, Jaehyun Kim

    Background: The burden of severe pediatric obesity is increasing globally, including in South Korea, and associated with metabolic and cardiovascular complications. However, longitudinal data of Korean children with severe obesity are limited.Purpose: This study evaluated the changes in body mass index (BMI) and associated metabolic syndrome components in children and adolescents with severe obesity managed without pharmacological or surgical treatment.Methods: We retrospectively reviewed participants diagnosed with severe obesity (BMI ≥120% of the 95th percentile) before the age of 18 years at 3 medical centers in 2017–2024. Participants with more than 1 year of follow-up were included. Management consisted exclusively of lifestyle modifications, including nutritional counseling and physician-led education on physical activity, screen time, and sleep. Patients with chronic illnesses, with psychiatric disorders, or who were taking medications that affect weight were excluded. The primary outcome was the change in BMI z score from baseline to the last visit. Predictors of a change in the BMI z score were analyzed using multivariable linear regression with adjustment for age, sex, pubertal stage, baseline BMI z score, and follow-up duration and frequency.Results: Among 124 participants (mean age, 9.69±3.39 years; 61.3% boys) followed for a mean duration of 2.64±1.51 years, BMI z scores significantly decreased (from 3.68±0.75 to a mean change of -0.27±0.79, P<0.001). Younger age and male sex were associated with greater reductions in BMI z scores. However, most participants remained severely obese. Except for modest improvements in liver transaminase levels, no substantial differences were observed in other metabolic syndrome components.Conclusion: Lifestyle modification resulted in a modest BMI z score reduction; however, most participants remained severely obese with no significant improvements in most metabolic syndrome components. These findings underscore the need for early and intensive interventions for pediatric obesity.

  • Open Access

    Clinical accuracy of Dexcom G6 and G7 continuous glucose monitors in hospitalized pediatric patients with type 1 diabetes: a real-world study

    by Dong Jun Ha, Ha Kyoung Lee, Jeong Ho Han, Mi Yang, Hwa Young Kim, Jaehyun Kim

    Purpose: Continuous glucose monitoring (CGM) is increasingly being used in inpatient pediatric diabetes care; however, data on its real-world accuracy remain limited.Methods: We retrospectively assessed the clinical accuracy of factory-calibrated Dexcom G6 and G7 CGM systems in 69 pediatric patients with type 1 diabetes at a Korean tertiary hospital between 2019 and 2025. A total of 1,838 CGM readings were temporally paired with point-of-care (POC) capillary glucose measurements. Accuracy was evaluated using the mean absolute relative difference (MARD), mean absolute difference (MAD), Bland-Altman analysis, and Clarke error grid classification. Subgroup analyses were performed according to wear day, glucose range, care setting, and CGM type.Results: The overall MARD was 10.6%±10.1% and MAD was 15.4±16.2 mg/dL. Accuracy improved over time, with MARD declining from 13.8% (G6) and 11.0% (G7) on day 1 to <10% on days 6 and 4, respectively. Bland-Altman limits narrowed from ±60 to ±39 mg/dL. During Days 6–11, 85.9% of CGM-POC pairs were within Clarke zone A and 94.1% within zones A and B. The MAD increased with higher glucose levels, whereas the MARD was highest during hypoglycemia (15.2%) and lowest during hyperglycemia (8.5 %). Intensive care unit admission significantly increased the MAD (p<0.001) without affecting the MARD. G7 demonstrated superior accuracy compared with G6 (pooled MARD: 9.8% vs. 11.2%, p=0.003). Mixed-effects modeling confirmed that wear day was an independent predictor of accuracy improvement (-0.34% MARD/day, p=0.001).Conclusion: The Dexcom G6 and G7 CGM systems met the ISO (International Organization for Standardization) 15197:2013 and U.S. Food and Drug Administration integrated-CGM criteria after a short inpatient stabilization period.


  • Open Access

    Familial Occurrence of Type 1 Diabetes Mellitus in Korean Children and Adolescents: A Multicenter Study

    by Hae Sang Lee, Hwa Young Kim, Mi Yang, Yun Jeong Kim, Hyun Wook Chae, Kyungchul Song, Aram Yang, Hyo-Kyoung Nam, Young-Jun Rhie, Eungu Kang, et al.

    Data on the familial occurrence of type 1 diabetes mellitus (T1DM) in Korean pediatric populations are limited. This study evaluated the clinical characteristics of children with T1DM according to family history and estimated the T1DM prevalence among relatives. We conducted a multicenter retrospective cohort study including patients aged ≤18 years newly diagnosed with T1DM at 18 university-affiliated hospitals in Korea between 2010 and 2024. The index child was defined as the first sibling diagnosed with T1DM and categorized according to the presence of affected parents or siblings. Familial T1DM prevalence was calculated for siblings, first-degree relatives, and twin pairs. Among 936 index children, 32 (3.4%) exhibited a T1DM family history. Compared with index children, subsequent-affected children presented with lower plasma glucose (300.0 mg/dL vs. 412.0 mg/dL, P=0.009) and glycosylated hemoglobin levels (10.4% vs. 12.6%, P<0.001), and a lower frequency of diabetic ketoacidosis (13.8% vs. 49.7%, P<0.001). Venous pH and serum bicarbonate levels were higher (7.4 vs. 7.3, P=0.005; 22.0 mmol/L vs. 17.0 mmol/L, P=0.004, respectively), whereas urine ketone levels were significantly lower (P<0.001). Sibling, first-degree relative, and twin-pair prevalence rates were 3.0% (23/779), 1.3% (34/2,651), and 42.9% (3/7), respectively. In this multicenter Korean cohort, familial T1DM accounted for 3.4% of pediatric cases, which was lower than in Western populations. Subsequent-affected children exhibited milder metabolic decompensation at diagnosis than did index children, likely reflecting earlier recognition through family awareness and screening. These findings underscore the importance of early education and monitoring of at-risk relatives within affected families.

  • Open Access

    Prevalence, Diagnostic Role, and Clinical Features of Zinc Transporter 8 Autoantibody in Korean Children and Adolescents With Diabetes Mellitus

    by Sohyun Shin, Hyun Ah Woo, Hakyung Lee, Yun Jeong Lee, Hwa Young Kim, Young Ah Lee, Choong Ho Shin, Ho Young Lee, Jaehyun Kim

    Shin S, et al. J Korean Med Sci. 2026 Oct;41:e118. https://doi.org/10.3346/jkms.2026.41.e118

  • Open Access

    Clinical and Genetic Significance of Chromosomal Microarray Screening of Asymptomatic Newborns

    by Naye Choi, Hwa Young Kim, Jung Min Ko

    Introduction: In South Korea, low‐resolution chromosomal microarray analysis (LR‐CMA) is frequently used as a screening tool to identify chromosomal anomalies in asymptomatic newborns. However, its clinical utility remains controversial. Methods: We retrospectively analyzed 99 asymptomatic newborns who underwent diagnostic CMA following abnormal LR‐CMA screening results at a single tertiary hospital between 2019 and 2024. Clinical features, copy number variant (CNV) findings, and follow‐up outcomes were assessed. Results: Among the 99 patients (57.6% male), the median ages at the initial and last visits were 0.3 and 1.0 years, respectively. A total of 171 CNVs were identified, of which 85 (49.7%) were classified as pathogenic or likely pathogenic. Overall, 70 of 99 (70.7%) patients harbored microduplication or deletions with syndromic implications. Developmental delay was identified in 10 (10.1%) patients. Notably, no significant associations were found between CNV pathogenicity and prenatal history, presence of anomalies, developmental delays, or growth parameters. Conclusions: Although a high rate of clinically significant CNVs was detected through LR‐CMA screening, only a minority of asymptomatic newborns exhibited developmental concerns within the observed follow‐up period. These findings suggest that while LR‐CMA may identify genetic alterations of interest, its routine use in asymptomatic newborns warrants careful consideration of clinical relevance and potential psychosocial impact.


  • Open Access

    Real-World Outcomes of Hybrid Closed-Loop System Use in Korean Youth With Childhood-Onset Type 1 Diabetes

    by Hyun Ah Woo, Su Jin Jeong, Yun Jeong Lee, Hwa Young Kim, Minjeong Gu, Ji Young Kim, Jaehyun Kim, Choong Ho Shin, Young Ah Lee

    Woo HA, et al. J Korean Med Sci. 2025 Dec;41:e34. https://doi.org/10.3346/jkms.2026.41.e34

  • Open Access

    Continuous glucose monitoring in Korean pediatric patients with type 1 diabetes: current landscape and clinical implications

    by Hwa Young Kim, Jaehyun Kim

    Continuous glucose monitoring (CGM) has become a key component in the management of pediatric type 1 diabetes mellitus (T1DM) since it offers real-time glucose data that facilitate tighter glycemic control and reduce acute complications. Accumulating evidence and international guidelines highlight the clinical efficacy, safety, and feasibility of CGM use in children, particularly those with high adherence. Regular CGM use is associated with significant reductions in glycated hemoglobin, fewer hypo- and hyperglycemia episodes, and improved quality of life for both patients and their caregivers. Recent advances in CGM technology—including improved accuracy, extended sensor wear, factory calibration, and customizable alerts—have enhanced their usability in pediatric populations. In addition to established CGM metrics such as time in range, time below range, and glycemic variability, a novel parameter—time in tight range (also referred as time in normoglycemia), defined as the percentage of time with blood glucose readings within 70–140 mg/dL—has emerged as a potentially more sensitive marker of optimal glycemic control in children. This review provides a comprehensive overview of CGM technologies, including device types, performance metrics, and clinical evidence supporting their use for pediatric T1DM. It also examines recent advancements in Korea such as expanded insurance reimbursement and clinical integration. As CGM becomes more accessible and technologically advanced, it is expected to play an increasingly central role in optimizing long-term outcomes for children and adolescents with T1DM.